Good point on the FDA involvement in biotechnology and pharmaceutical stock. Since I am a new investor the FDA is definitely something else equal to factor in with research.
Is this stock a shame, or am i miss interpreting something? Although I am new to the site and heard of this stock from my boss, I saw one should be cautious. my boss has shares in BHUB and recently said the co was trying to buy back their shares. maybe this is what is causing confusion?
I heard of this stock from my boss at work. He has had this stock for years. In fact, he said he has had XOMA for more than 10 or 15 years. He holds strong with his biotechnology shares, and bets on XOMA which seems to want to stick around.
Re: Investing in Gold, Silver and Technology Stocks, Today’s Tr..06/13/08
Since reading this older analysis by SocialPicks Sentiment, it was interesting that the thought, -eventual VEBAV price was between $2.50-$2.80. It is now on Friday-the-thirteenth @ $3.50. Though I looked into this stock and found little analysis information, take the research approach. Be cautious; one might want to look into this stock a little more, before anyone buys.
Data powered by FinancialContent.
All Rights Reserved.
Quotes delayed at least 20 minutes unless otherwise indicated.
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.